Cubist Systematic Strategies LLC Acquires Shares of 424,048 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cubist Systematic Strategies LLC bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 424,048 shares of the medical instruments supplier's stock, valued at approximately $8,048,000. Cubist Systematic Strategies LLC owned approximately 0.21% of DENTSPLY SIRONA as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. raised its position in DENTSPLY SIRONA by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after buying an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC raised its holdings in shares of DENTSPLY SIRONA by 2.5% in the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after purchasing an additional 348,532 shares during the last quarter. Nuance Investments LLC lifted its position in shares of DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after purchasing an additional 2,708,097 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of DENTSPLY SIRONA by 18.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after purchasing an additional 1,975,404 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its holdings in DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock worth $219,018,000 after purchasing an additional 314,343 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business's stock in a transaction on Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.50% of the stock is owned by insiders.

DENTSPLY SIRONA Trading Down 0.6 %

NASDAQ:XRAY traded down $0.10 during mid-day trading on Friday, hitting $15.81. 4,397,789 shares of the stock traded hands, compared to its average volume of 2,959,440. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $3.15 billion, a price-to-earnings ratio of -7.64, a PEG ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $28.69. The firm's 50 day moving average is $14.36 and its two-hundred day moving average is $17.58.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. During the same period in the previous year, the firm earned $0.42 earnings per share. The business's revenue was down 7.8% on a year-over-year basis. On average, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.05%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA's payout ratio is currently -14.10%.

Analyst Ratings Changes

Several analysts have commented on the stock. Wells Fargo & Company lowered their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Mizuho reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. UBS Group lowered their target price on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research note on Friday. Finally, Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and cut their price target for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Eleven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $20.27.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.